• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MDT SOFAMOR DANEK PUERTO RICO MFG ENTERRA; INTESTINAL STIMULATOR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MDT SOFAMOR DANEK PUERTO RICO MFG ENTERRA; INTESTINAL STIMULATOR Back to Search Results
Model Number 7425G
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Nausea (1970); Therapeutic Effects, Unexpected (2099); Vomiting (2144); Distress (2329); Weight Changes (2607)
Event Date 04/16/2003
Event Type  Injury  
Manufacturer Narrative
A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
 
Event Description
The consumer reported that the patient had no therapeutic benefit since implant on (b)(6) 2003.The patient started vomiting and at that time weighed (b)(6).The patient had gotten down to where they only weighed (b)(6).Because of all the nausea and vomiting.The patient was very skinny and had to travel to where they got the stimulator placed because they needed a j-tube placed in order to be fed.It was a lot of stress.It was hard to say if the patient had any improvement at all because they were at (b)(6).When they had the j-tube put in and after it was put in, they were able to keep medication in and do things they weren't able to medically do before.The patient did see a little change of doing better, but they were still in the hospital 10 to 15 times a year for at least a week because they had nausea and vomiting and it wouldn't stop.The patient mentioned having diabetes, which had attributed to other health problems they had and gastroparesis.The patient had not had a 50 percent or greater reduction in symptoms.The patient moved on to get implanted with another implant on (b)(6) 2012, the one they currently had now, and their symptoms had improved by 90 percent with the current implant.The indication for use for this patient was gastric stimulation.
 
Manufacturer Narrative
If information is provided in the future, a supplemental report will be issued.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ENTERRA
Type of Device
INTESTINAL STIMULATOR
Manufacturer (Section D)
MDT SOFAMOR DANEK PUERTO RICO MFG
barrio marianna rd 909, km0.4
humacao PR 00792
Manufacturer (Section G)
MDT SOFAMOR DANEK PUERTO RICO MFG
barrio marianna rd 909, km0.4
humacao PR 00792
Manufacturer Contact
diane wolf
7000 central avenue ne rcw215
minneapolis, MN 55432
7635263987
MDR Report Key5808699
MDR Text Key49982714
Report Number6000032-2016-00089
Device Sequence Number1
Product Code LNQ
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
H990014
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type consumer
Reporter Occupation Other
Type of Report Initial,Followup
Report Date 07/20/2016
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received07/20/2016
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date06/28/2004
Device Model Number7425G
Device Catalogue Number7425G
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? No
Date Manufacturer Received06/29/2016
Date Device Manufactured01/07/2003
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Required Intervention;
Patient Age34 YR
-
-